195 related articles for article (PubMed ID: 23296781)
1. BRET approaches to characterize dopamine and TAAR1 receptor pharmacology and signaling.
Espinoza S; Masri B; Salahpour A; Gainetdinov RR
Methods Mol Biol; 2013; 964():107-22. PubMed ID: 23296781
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor.
Barak LS; Salahpour A; Zhang X; Masri B; Sotnikova TD; Ramsey AJ; Violin JD; Lefkowitz RJ; Caron MG; Gainetdinov RR
Mol Pharmacol; 2008 Sep; 74(3):585-594. PubMed ID: 18524885
[TBL] [Abstract][Full Text] [Related]
3. BRET biosensors to study GPCR biology, pharmacology, and signal transduction.
Salahpour A; Espinoza S; Masri B; Lam V; Barak LS; Gainetdinov RR
Front Endocrinol (Lausanne); 2012; 3():105. PubMed ID: 22952466
[TBL] [Abstract][Full Text] [Related]
4. Methods to Monitor the Trafficking of β-Arrestin/G Protein-Coupled Receptor Complexes Using Enhanced Bystander BRET.
Cao Y; Namkung Y; Laporte SA
Methods Mol Biol; 2019; 1957():59-68. PubMed ID: 30919346
[TBL] [Abstract][Full Text] [Related]
5. Bioluminescence Resonance Energy Transfer (BRET) to Detect the Interactions Between Kappa Opioid Receptor and Nonvisual Arrestins.
Bedini A
Methods Mol Biol; 2021; 2201():45-58. PubMed ID: 32975788
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling.
Klewe IV; Nielsen SM; Tarpø L; Urizar E; Dipace C; Javitch JA; Gether U; Egebjerg J; Christensen KV
Neuropharmacology; 2008 Jun; 54(8):1215-22. PubMed ID: 18455202
[TBL] [Abstract][Full Text] [Related]
7. Detection of β-Arrestin-Mediated G Protein-Coupled Receptor Ubiquitination Using BRET.
Nagi K; Shenoy SK
Methods Mol Biol; 2019; 1957():93-104. PubMed ID: 30919349
[TBL] [Abstract][Full Text] [Related]
8. Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers.
Harmeier A; Obermueller S; Meyer CA; Revel FG; Buchy D; Chaboz S; Dernick G; Wettstein JG; Iglesias A; Rolink A; Bettler B; Hoener MC
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2049-61. PubMed ID: 26372541
[TBL] [Abstract][Full Text] [Related]
9. Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET.
Namkung Y; Le Gouill C; Lukashova V; Kobayashi H; Hogue M; Khoury E; Song M; Bouvier M; Laporte SA
Nat Commun; 2016 Jul; 7():12178. PubMed ID: 27397672
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.
Masri B; Salahpour A; Didriksen M; Ghisi V; Beaulieu JM; Gainetdinov RR; Caron MG
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13656-61. PubMed ID: 18768802
[TBL] [Abstract][Full Text] [Related]
11. Bioluminescence resonance energy transfer (BRET) to detect the interactions between kappa opioid receptor and non visual arrestins.
Bedini A
Methods Mol Biol; 2015; 1230():115-28. PubMed ID: 25293320
[TBL] [Abstract][Full Text] [Related]
12. Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors.
Namkung Y; LeGouill C; Kumar S; Cao Y; Teixeira LB; Lukasheva V; Giubilaro J; Simões SC; Longpré JM; Devost D; Hébert TE; Piñeyro G; Leduc R; Costa-Neto CM; Bouvier M; Laporte SA
Sci Signal; 2018 Dec; 11(559):. PubMed ID: 30514808
[TBL] [Abstract][Full Text] [Related]
13. Real-time examination of cAMP activity at relaxin family peptide receptors using a BRET-based biosensor.
Valkovic AL; Leckey MB; Whitehead AR; Hossain MA; Inoue A; Kocan M; Bathgate RAD
Pharmacol Res Perspect; 2018 Oct; 6(5):e00432. PubMed ID: 30263124
[TBL] [Abstract][Full Text] [Related]
14. Measuring Recruitment of β-Arrestin to G Protein-Coupled Heterodimers Using Bioluminescence Resonance Energy Transfer.
Fillion D; Devost D; Hébert TE
Methods Mol Biol; 2019; 1957():83-91. PubMed ID: 30919348
[TBL] [Abstract][Full Text] [Related]
15. Quantifying biased signaling in GPCRs using BRET-based biosensors.
Namkung Y; Radresa O; Armando S; Devost D; Beautrait A; Le Gouill C; Laporte SA
Methods; 2016 Jan; 92():5-10. PubMed ID: 25890247
[TBL] [Abstract][Full Text] [Related]
16. NanoLuc-Based Methods to Measure β-Arrestin2 Recruitment to G Protein-Coupled Receptors.
Ma X; Leurs R; Vischer HF
Methods Mol Biol; 2021; 2268():233-248. PubMed ID: 34085273
[TBL] [Abstract][Full Text] [Related]
17. Biased signaling at chemokine receptors.
Corbisier J; Galès C; Huszagh A; Parmentier M; Springael JY
J Biol Chem; 2015 Apr; 290(15):9542-54. PubMed ID: 25614627
[TBL] [Abstract][Full Text] [Related]
18. Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.
Free RB; Chun LS; Moritz AE; Miller BN; Doyle TB; Conroy JL; Padron A; Meade JA; Xiao J; Hu X; Dulcey AE; Han Y; Duan L; Titus S; Bryant-Genevier M; Barnaeva E; Ferrer M; Javitch JA; Beuming T; Shi L; Southall NT; Marugan JJ; Sibley DR
Mol Pharmacol; 2014 Jul; 86(1):96-105. PubMed ID: 24755247
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum.
Martínez-Pinilla E; Rodríguez-Pérez AI; Navarro G; Aguinaga D; Moreno E; Lanciego JL; Labandeira-García JL; Franco R
Biochem Pharmacol; 2015 Jul; 96(2):131-42. PubMed ID: 25986885
[TBL] [Abstract][Full Text] [Related]
20. Agonist-induced formation of unproductive receptor-G
Okashah N; Wright SC; Kawakami K; Mathiasen S; Zhou J; Lu S; Javitch JA; Inoue A; Bouvier M; Lambert NA
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21723-21730. PubMed ID: 32817560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
